Albert Bourla Net Worth, Bio, Age, Height, Wiki [Updated 2022]
Albert Bourla- Biography
Albert Bourla is the Chairman and Chief Executive Officer of ‘Pfizer,’ one of the world’s top pharmaceutical businesses. He is also a veterinarian. He is noted for his zealous leadership and lives by the motto “Breakthroughs that alter patients’ lives.” During his 25-year tenure as CEO of Pfizer, he has changed as a result of his diverse skill set. In terms of the present pandemic, Albert-led Pfizer has cleared the first two trials for the COVID-19 vaccine and is currently through its third phase trials; he believes that if all goes according to plan, Americans would be able to obtain their vaccine shot before the end of the year.
What is the Net Worth of Albert Bourla? Salary, Earnings
Albert Bourla, the apex position of the apex pharmaceutical corporation, is said to be paid close to $18 million. In addition, he owns a considerable quantity of Pfizer stock, which is presently valued at $37, and his net worth is estimated to be around $26.4 million.
Albert Bourla- Birth, Age, Ethnicity, Siblings, Education
Albert was born on October 21, 1961, in Thessaloniki, Greece, to Jewish parents. Little is known about his parents, however, he does not have any siblings.
Albert had wanted to be a doctor since he was a child, so after graduating from a local school in Thessaloniki in 1979, he enrolled at Aristotle University and earned a Ph.D. in Biotechnology and Reproduction. He worked as a Veterinary Doctor in Greece for a few years, inspired by his early love of animals. He was also interested in understanding technology’s power to push the boundaries of science and medicine, therefore he sought a career in that field.
|Real Name||Albert Bourla|
|Birth Date||October 21, 1961|
|Birth Place||Thessaloniki, Greece|
|Profession||Veterinarian & Business Tycoon|
Albert Bourla’s Professional Career
Albert used to work as a veterinarian in Greece throughout his early career. Later that year, in 1993, he began working for Pfizer as a Technical Director in the Animal Health Division in Greece. Given his considerable contributions to the improvement of animal health throughout Europe, he was appointed as the US Group Marketing Director in New York in 2001. He has promoted to Vice President of Business Development and New Product Marketing after a few years. He was appointed Area President of Animal Health Europe, Asia, and the Middle East in 2006.
In 2010, he was promoted to General Manager for Pfizer’s established products business, where he was responsible for the implementation of Pfizer’s off-patent portfolio plans and tactics. As Group President of Pfizer’s global vaccines, oncology, and consumer healthcare businesses, he was instrumental in propelling them to new heights. Later, he was promoted to Chief Operating Officer, where he was in charge of the company’s commercial strategy, manufacturing, and global product development. He was appointed CEO of Pfizer in January 2019.
Albert Bourla- Relationship, Married Life
Albert presently resides in Scarsdale, New York with his wife, Myriam Alchanati Bourla. He left Greece at the age of 34 and has since lived in seven different cities and four other countries. The couple is the parents of two children, a son, and a daughter.
Body Measurements: Height, Weight, Hair color
|Height||in feet inches – 5’ 7” – in Centimetres – 170 cm Approx|
|Weight||in Kilograms – 63 kg – in Pounds – 138 lbs Approx|
|Shoe Size||8 (U.S.)|
|Hair Color||Dark Brown|
|Eye Color||Dark Brown|
Social Media Details
Albert Bourla does not have an official presence on social media platforms such as Twitter, Instagram, Facebook, YouTube, and TikTok.
- In his 25-year tenure at Pfizer, he has held as many as ten positions.
- Albert was named America’s top CEO in the Pharmaceuticals industry by Institutional Investor magazine in 2020.
- In addition to his work at Pfizer, he is a trustee of the United States Council for International Business and a member of the Business Roundtable and Business Council.
- He has never worked for a company other than Pfizer in his whole professional career.
- The Galien Foundation named Albert the ‘Preeminent Greek Leader’ in worldwide medicines.